{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:03:53Z","timestamp":1775012633196,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":2160,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:p> <jats:italic>In September, 2000, the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health called an early halt to the amlodipine arm of the African American Study of Kidney Disease and Hypertension (AASK) trial after careful deliberation by an independent data and safety monitoring board. An interim analysis of the AASK at 3 years revealed a renoprotective effect of the angiotensin\u2010converting enzyme inhibitor ramipril as compared to the dihydropyridine calcium channel blocker (DHP\u2010CCB) amlodipine in patients with mild to moderate renal insufficiency. This differential effect was independent of the blood pressure levels reached and was evident in both proteinuric and non\u2010proteinuric patients with hypertensive nephrosclerosis. The AASK trial data suggest that DHP\u2010CCBs should be used cautiously in the presence of mild to moderate renal insufficiency. Judgment should be reserved for the use of other CCBs, such as verapamil or diltiazem, since these are fundamentally different CCBs with the potential for a different impact on hypertensive nephrosclerosis. The blinded observation period for AASK will be completed at the end of September, 2001, at which time additional, clinically useful information is expected to become available.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2001.00474.x","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T08:29:35Z","timestamp":1180600175000},"page":"244-251","source":"Crossref","is-referenced-by-count":25,"title":["The African American Study of Kidney Disease and Hypertension (AASK): New Findings"],"prefix":"10.1111","volume":"3","author":[{"given":"Domenic A.","family":"Sica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice G.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.1997.03540400043029","article-title":"End\u2010stage renal disease in African\u2010American and white men. 16\u2010year MRFIT findings","volume":"277","author":"Klag MJ","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90001-2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90021-7"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(96)00081-5"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90125-6"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.5.685"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7130.504"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00001"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04433-X"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-10-199511150-00003"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.4.487"},{"key":"e_1_2_7_16_2","first-page":"328","article-title":"The losartan renal protection study\u2014rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)","volume":"1","author":"Brenner BM","year":"2000","journal-title":"J RAS"},{"key":"e_1_2_7_17_2","first-page":"406","article-title":"The Heart Outcomes Prevention Evaluation (HOPE) Study: limitations and strengths","volume":"2","author":"Sica DA","year":"2000","journal-title":"J Clin Hypertens"},{"key":"e_1_2_7_18_2","first-page":"S3","article-title":"Mechanism of progression of renal disease: current hemodynamic concepts","volume":"16","author":"Johnston CI","year":"1998","journal-title":"J Hypertens"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.20734"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.5.1131"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000025907"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.16225"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00077-6"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1185\/0300799009117011"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10363-X"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00912.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00083.x"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2001.00474.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2001.00474.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:12:55Z","timestamp":1697631175000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2001.00474.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1111\/j.1524-6175.2001.00474.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2001.00474.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}